Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects
Clinical trial NCT05219461 · COMPLETED
Trial details
- NCT number
- NCT05219461
- Sponsor
- Daewoong Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2019-11-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.